ReadYourDNA

rs9277535 (HLA-DPB1)

What you carry at this position in your DNA and what research says about it.

Hepatitis B Risk: 9/10 evidence, 33 publications.

You're viewing every possible genotype for this variant.

None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.

Sample genotype (not yours): A/A

Lower Hepatitis B Risk and Stronger Vaccine Response

This genotype is linked to a significantly lower risk of developing chronic hepatitis B and a more robust antibody response to the hepatitis B vaccine.

What this genotype means: Lower risk of chronic hepatitis B; Stronger antibody response to vaccination.

Sample genotype (not yours): A/G

Typical Hepatitis B Risk and Vaccine Response

Carrying one copy of each allele provides a balanced immune profile with typical susceptibility to hepatitis B and standard vaccine responsiveness.

What this genotype means: Typical risk of chronic hepatitis B; Standard response to hepatitis B vaccination.

Sample genotype (not yours): G/G

Higher Hepatitis B Risk and Weaker Vaccine Response

This genotype is associated with an increased risk of persistent or chronic hepatitis B infection and a lower likelihood of developing strong antibody protection from the vaccine.

What this genotype means: Increased risk of chronic hepatitis B; Weaker antibody response to vaccination.

About HLA-DPB1

Gene function and biological role

Gene Function: The HLA-DPB1 gene encodes a critical component of the human leukocyte antigen class II complex, which plays a central role in the immune system. This complex is responsible for presenting foreign antigens, such as viral proteins, to T-helper cells to initiate an immune response [1]. Proper antigen presentation is essential for clearing infections and developing long-term immunity [2]. Variations in this gene can significantly affect how well the immune system recognizes specific pathogens, particularly the hepatitis B virus [3]. Consequently, HLA-DPB1 is a major genetic determinant of infectious disease susceptibility and vaccine efficacy [4].

Variant Impact: The rs9277535 variant is a single nucleotide polymorphism located in the 3 prime untranslated region of the HLA-DPB1 gene. This specific genetic change influences the expression levels of the HLA-DPB1 messenger RNA in liver tissues [5]. Lower expression of this molecule can impair the presentation of viral antigens, making it harder for the body to clear certain infections [6]. Conversely, higher expression levels are associated with more effective immune surveillance and viral clearance [3]. This variant is particularly well-studied in Asian populations, where it represents a key genetic marker for hepatitis B outcomes [1].

Key Insight: This genetic variant influences both your natural ability to clear the hepatitis B virus and how strongly your immune system responds to the hepatitis B vaccine.

Location: HLA-DPB1. Chromosome 6 · 6p21.32 · 33.1 Mb

Genotype Frequencies

Estimated prevalence by population

Global 56.6%; European 57.0%; African 57.4%; East Asian 14.1%; South Asian 53.9%; Americas 58.5%; Ashkenazi 68.5%; Finnish 63.8%; Middle Eastern 58.8%; Amish 80.4%.

Estimated AA genotype frequency.

Global 36.6%; European 37.0%; African 36.7%; East Asian 46.9%; South Asian 39.0%; Americas 36.0%; Ashkenazi 28.5%; Finnish 32.1%; Middle Eastern 35.7%; Amish 18.5%.

Estimated AG genotype frequency.

Global 6.9%; European 6.0%; African 5.9%; East Asian 39.0%; South Asian 7.1%; Americas 5.5%; Ashkenazi 3.0%; Finnish 4.0%; Middle Eastern 5.4%; Amish 1.1%.

Estimated GG genotype frequency.

Associated Traits

Showing effects for A/A genotype

Immunity & Inflammation

Infection Susceptibility & Resistance

Hepatitis B. Evidence: 9/10. Source: PMID 19349983. Lower Risk.

Vaccine Response. Evidence: 4/10. Source: PMID 21764829. Stronger Response.

Showing effects for A/G genotype

Hepatitis B. Evidence: 9/10. Source: PMID 19349983. Typical Risk.

Vaccine Response. Evidence: 4/10. Source: PMID 21764829. Typical Response.

Showing effects for G/G genotype

Hepatitis B. Evidence: 9/10. Source: PMID 19349983. ~1.6x Higher Risk.

Vaccine Response. Evidence: 4/10. Source: PMID 21764829. Weaker Response.

What AA Genotype Means

What this genotype means for the people who carry it

Sample genotype: AA (Homozygous)

Lower risk of chronic hepatitis B infection is the primary feature of this genotype [1]. The immune system is highly efficient at presenting hepatitis B viral antigens, which facilitates spontaneous clearance of the virus if exposed [2]. Furthermore, this genetic profile is linked to a significantly stronger antibody response following hepatitis B vaccination [3]. This means the vaccine is highly likely to provide robust, long-term protective immunity [3]. Overall, the protective benefits against hepatitis B represent a major health advantage, especially in regions where the virus is common [4]. Maintaining standard vaccination records and routine health checkups remains the best practice for overall wellness.

Lower risk of chronic hepatitis B; Stronger antibody response to vaccination.

What AG Genotype Means

Sample genotype: AG (Heterozygous)

Typical baseline risk of hepatitis B infection characterizes this heterozygous genotype [1]. The immune system expresses a balanced level of HLA-DPB1 molecules, resulting in standard antigen presentation capabilities [2]. Response to the hepatitis B vaccine is generally typical, with most people developing adequate protective antibody levels [3]. Spontaneous clearance rates of the virus are also within the average range for the general population [4]. While there is no elevated risk of chronic infection, there is also no exceptional genetic protection [1]. Standard preventative measures, such as completing the recommended vaccine series, are highly effective [3]. This genotype represents the most common genetic profile in many global populations.

Typical risk of chronic hepatitis B; Standard response to hepatitis B vaccination.

What GG Genotype Means

Sample genotype: GG (Homozygous)

Higher risk of developing a persistent, chronic hepatitis B infection is associated with this genotype [1]. The immune system may express lower levels of the HLA-DPB1 molecule, which can hinder the effective presentation of viral antigens to T cells [2]. Consequently, if exposed to the virus, the body is less likely to clear it spontaneously, increasing the chance of lifelong infection [3]. Additionally, this genetic profile is linked to a weaker antibody response to the hepatitis B vaccine, meaning standard vaccination might be less effective at inducing full immunity [4]. Knowing this status can help healthcare providers optimize immunization strategies, such as checking antibody titers after vaccination [4]. Standard precautions against viral exposure remain highly recommended.

Increased risk of chronic hepatitis B; Weaker antibody response to vaccination.

Related Variants

Variants with shared genetic architecture

rs10484554 · HLA-C Gene · Chr 6 · Psoriasis Risk

rs11052877 · CD69 Gene · Chr 12 · Thyroid Disease Risk

rs1800973 · LYZ Gene · Chr 12 · Mouth Ulcer Risk

Sources

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region.

Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.

Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment.

Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver.

A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection.

Back to Variant Explorer

Content updated August 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com